Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells.
D002294:Carcinoma, Squamous Cell / Q000473:pathology; D002455:Cell Division / Q000187:drug effects*; D002460:Cell Line; D003260:Contact Inhibition; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D066246:ErbB Receptors; D006801:Humans; D011494:Protein Kinases / Q000378:metabolism*; D011956:Receptors, Cell Surface / Q000187:drug effects
D011956:Receptors, Cell Surface; D004815:Epidermal Growth Factor; D011494:Protein Kinases; D066246:ErbB Receptors